4D Molecular Therapeutics, Inc. - Common Stock (FDMT)
CUSIP: 35104E100
Q1 2021 13F Holders as of 31 Mar 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 50,943,214
- Total 13F shares
- 15,384,514
- Share change
- +775,033
- Total reported value
- $664,816,567
- Price per share
- $43.38
- Number of holders
- 63
- Value change
- +$34,097,345
- Number of buys
- 38
- Number of sells
- 29
Quarterly Holders Quick Answers
What is CUSIP 35104E100?
CUSIP 35104E100 identifies FDMT - 4D Molecular Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 35104E100:
Top shareholders of FDMT - 4D Molecular Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
7.7%
|
3,937,914
|
$163,227,000 | — | 31 Dec 2020 | |
| FMR LLC |
13F
|
Company |
3.1%
|
1,594,355
|
$66,086,000 | — | 31 Dec 2020 | |
| BVF INC/IL |
13F
|
Company |
2.2%
|
1,106,070
|
$45,847,000 | — | 31 Dec 2020 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
2.1%
|
1,063,744
|
$44,092,000 | — | 31 Dec 2020 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2%
|
1,021,911
|
$39,907,000 | — | 31 Dec 2020 | |
| Casdin Capital, LLC |
13F
|
Company |
1.5%
|
780,555
|
$32,354,000 | — | 31 Dec 2020 | |
| SB Management Ltd |
13F
|
Company |
1.4%
|
717,734
|
$29,750,000 | — | 31 Dec 2020 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.2%
|
600,256
|
$24,881,000 | — | 31 Dec 2020 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.79%
|
401,885
|
$16,658,000 | — | 31 Dec 2020 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.74%
|
377,777
|
$15,659,000 | — | 31 Dec 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.68%
|
344,283
|
$14,271,000 | — | 31 Dec 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.67%
|
343,678
|
$14,245,000 | — | 31 Dec 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.48%
|
245,705
|
$10,184,000 | — | 31 Dec 2020 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
0.44%
|
225,000
|
$9,326,000 | — | 31 Dec 2020 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.41%
|
209,179
|
$8,670,000 | — | 31 Dec 2020 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.39%
|
200,000
|
$8,290,000 | — | 31 Dec 2020 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.29%
|
150,000
|
$6,218,000 | — | 31 Dec 2020 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.29%
|
150,000
|
$6,218,000 | — | 31 Dec 2020 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.29%
|
150,000
|
$6,218,000 | — | 31 Dec 2020 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.25%
|
125,000
|
$5,181,000 | — | 31 Dec 2020 | |
| Woodline Partners LP |
13F
|
Company |
0.2%
|
103,453
|
$4,288,000 | — | 31 Dec 2020 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.2%
|
100,000
|
$4,145,000 | — | 31 Dec 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.15%
|
74,978
|
$3,108,000 | — | 31 Dec 2020 | |
| Laurion Capital Management LP |
13F
|
Company |
0.11%
|
58,000
|
$2,404,000 | — | 31 Dec 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.1%
|
52,463
|
$2,175,000 | — | 31 Dec 2020 | |
| Eagle Health Investments LP |
13F
|
Company |
0.1%
|
50,000
|
$2,073,000 | — | 31 Dec 2020 | |
| J. Goldman & Co LP |
13F
|
Company |
0.09%
|
48,287
|
$2,001,000 | — | 31 Dec 2020 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.07%
|
35,825
|
$1,485,000 | — | 31 Dec 2020 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.07%
|
34,444
|
$1,428,000 | — | 31 Dec 2020 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.07%
|
33,680
|
$1,396,000 | — | 31 Dec 2020 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.07%
|
33,152
|
$1,374,000 | — | 31 Dec 2020 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.05%
|
27,448
|
$1,138,000 | — | 31 Dec 2020 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.04%
|
20,000
|
$829,000 | — | 31 Dec 2020 | |
| Aquilo Capital Management, LLC |
13F
|
Company |
0.04%
|
20,000
|
$829,000 | — | 31 Dec 2020 | |
| Pinz Capital Management, LP |
13F
|
Company |
0.04%
|
19,900
|
$825,000 | — | 31 Dec 2020 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.03%
|
16,496
|
$684,000 | — | 31 Dec 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
12,780
|
$529,000 | — | 31 Dec 2020 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.02%
|
12,000
|
$498,000 | — | 31 Dec 2020 | |
| M&T BANK CORP |
13F
|
Company |
0.02%
|
10,495
|
$435,000 | — | 31 Dec 2020 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.02%
|
10,000
|
$415,000 | — | 31 Dec 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.02%
|
10,000
|
$415,000 | — | 31 Dec 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.02%
|
10,000
|
$414,000 | — | 31 Dec 2020 | |
| MIRABELLA FINANCIAL SERVICES LLP |
13F
|
Company |
0.02%
|
8,330
|
$345,000 | — | 31 Dec 2020 | |
| Engineers Gate Manager LP |
13F
|
Company |
0.02%
|
8,139
|
$337,000 | — | 31 Dec 2020 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.01%
|
7,436
|
$308,000 | — | 31 Dec 2020 | |
| Maven Securities LTD |
13F
|
Company |
0.01%
|
6,500
|
$271,000 | — | 31 Dec 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.01%
|
5,928
|
$246,000 | — | 31 Dec 2020 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.01%
|
5,224
|
$217,000 | — | 31 Dec 2020 | |
| CAAS CAPITAL MANAGEMENT LP |
13F
|
Company |
0.01%
|
5,000
|
$207,000 | — | 31 Dec 2020 | |
| NORGES BANK |
13F
|
Company |
0.01%
|
5,000
|
$207,000 | — | 31 Dec 2020 |
Institutional Holders of 4D Molecular Therapeutics, Inc. - Common Stock (FDMT) as of Q1 2021
As of 31 Mar 2021,
4D Molecular Therapeutics, Inc. - Common Stock (FDMT) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,384,514 shares.
The largest 10 holders included
VIKING GLOBAL INVESTORS LP, FMR LLC, JANUS HENDERSON GROUP PLC, ArrowMark Colorado Holdings LLC, BVF INC/IL, Casdin Capital, LLC, BlackRock Inc., PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, and ALKEON CAPITAL MANAGEMENT LLC.
This page lists
63
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
51
Q1 2021 holders
63
Holder diff
12
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.